Edwards Lifesciences Corporation (EW) Earnings History
Annual and quarterly earnings data from 1999 to 2025
Loading earnings history...
EW EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
EW Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 78.1% | 27.0% | 17.7% |
| 2024 | 79.5% | 25.3% | 76.7% |
| 2023 | 79.3% | 28.5% | 28.0% |
| 2022 | 78.3% | 31.6% | 28.3% |
| 2021 | 76.6% | 30.8% | 28.7% |
Download Data
Export EW earnings history in CSV or JSON format
Free sign-in required to download data
Edwards Lifesciences Corporation (EW) Earnings Overview
As of May 8, 2026, Edwards Lifesciences Corporation (EW) reported trailing twelve-month net income of $1.07B, reflecting -73.7% year-over-year growth. The company earned $1.84 per diluted share over the past four quarters, with a net profit margin of 17.7%.
Looking at the long-term picture, EW's 5-year EPS compound annual growth rate (CAGR) stands at +7.1%, showing solid earnings momentum. The company achieved its highest annual net income of $4.17B in fiscal 2024.
Edwards Lifesciences Corporation maintains industry-leading profitability with a gross margin of 78.1%, operating margin of 27.0%, and net margin of 17.7%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including MDT ($4.61B net income, 13.9% margin), ABT ($13.98B net income, 31.9% margin), BSX ($2.89B net income, 14.4% margin), EW has outperformed on profitability metrics. Compare EW vs MDT →
EW Earnings vs Peers
Earnings metrics vs comparable public companies
EW Historical Earnings Data (1999–2025)
27 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $1.07B | -74.3% | $1.64B | $1.83 | 17.7% | 27.0% |
| 2024 | $4.17B | +197.7% | $1.38B | $6.97 | 76.7% | 25.3% |
| 2023 | $1.40B | -7.9% | $1.43B | $2.30 | 28.0% | 28.5% |
| 2022 | $1.52B | +1.3% | $1.70B | $2.44 | 28.3% | 31.6% |
| 2021 | $1.50B | +82.5% | $1.61B | $2.38 | 28.7% | 30.8% |
| 2020 | $823M | -21.3% | $1.30B | $1.30 | 18.8% | 29.5% |
| 2019 | $1.05B | +45.0% | $1.20B | $1.64 | 24.1% | 27.6% |
| 2018 | $722M | +16.1% | $1.09B | $1.13 | 19.4% | 29.3% |
| 2017 | $622M | +9.2% | $1.01B | $0.96 | 18.1% | 29.4% |
| 2016 | $570M | +15.1% | $816M | $0.87 | 19.2% | 27.5% |
Full EW Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See EW's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs EW Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare EW vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonEW — Frequently Asked Questions
Quick answers to the most common questions about buying EW stock.
Is EW growing earnings?
EW EPS fell to $1.84, with earnings declining -73.7%. This contrasts with the 5-year CAGR of +7.1%. TTM net income dropped to $1.1B.
What are EW's profit margins?
Edwards Lifesciences Corporation net margin is +17.7%, with operating margin at +27.0%. Above-average margins indicate pricing power.
How consistent are EW's earnings?
EW earnings data spans 1999-2025. The declining earnings trend is -73.7% YoY. Historical data enables comparison across business cycles.